Showing results (1-10 of 422) with videos related to
Sort By:
Pageof 43
Current Atherosclerosis Reports|December 26, 2025
Fibrates : Do They Still Have a Role in Therapy in 2025?Angela Pirillo, Alberto Zambon, Alberico L CatapanoCurrent Atherosclerosis Reports|October 3, 2020
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein ReductionAlberto Zambon, Angela Pirillo, Sabina Zambon, et al.Atherosclerosis. Supplements|August 21, 2013
Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemiaAngela Pirillo, Alberico L CatapanoExpert Opinion on Biological Therapy|June 14, 2022
Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemiaAngela Pirillo, Alberico L CatapanoCurrent Atherosclerosis Reports|December 20, 2023
How to Handle Elevated Triglycerides: Life after PROMINENTAngela Pirillo, Alberico L CatapanoCurrent Opinion in Lipidology|November 5, 2025
The two faces of cholesteryl ester transfer protein inhibitorsAngela Pirillo, Alberico L CatapanoCurrent Opinion in Endocrinology, Diabetes, and Obesity|January 4, 2022
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemiaAngela Pirillo, Alberico L CatapanoAtherosclerosis. Supplements|July 19, 2017
Pitavastatin and HDL: Effects on plasma levels and function(s)Angela Pirillo, Alberico L CatapanoEuropean Journal of Internal Medicine|July 26, 2025
Lipoprotein (a): A new target for pharmacological research and an option for treatmentAngela Pirillo, Alberico L CatapanoAtherosclerosis. Supplements|February 16, 2021
Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patientsGerald F Watts, Alberico L Catapano, Luis Masana, et al.Pageof 43